Rheonix
PrivateLast Round
Debt
Jun 18, 2020
Total Funding Raised
$49.55M
Company Overview
Rheonix operates in Healthcare & Life Sciences and is based in Ithaca, New York. Its latest recorded funding round was a Grant round in April 2016.
Rheonix is a biotechnology company that develops automated molecular diagnostics platforms and assays for clinical, research, and applied testing markets.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rheonix Comparables
Compare Rheonix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biocartis | 77% | |
| Clear Labs | 76% | |
| Danaher | 75% |
For institutional investors. Book with your work email.
Rheonix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 18, 2020 | ||||
| Grant | Apr 19, 2016 | ||||
| Series B | Oct 20, 2015 | ||||
| Grant | Feb 10, 2015 | ||||
| Grant | Apr 21, 2014 | ||||
VC Round | Dec 19, 2013 |
For institutional investors. Book with your work email.
Rheonix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Limestone Capital Advisors | Series B |
| NIH RADx | Grant |
| Advantage Capital | Series B |
| Onondaga Venture Capital Fund | Series A, Series B |
| National Institute of Dental and Craniofacial Research | Grant |
| Cayuga Venture Fund | Series A, VC Round, Series B |
| Rand Capital BDC | Series A, Series B, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2020
Completed a debt financing round.
- Apr 19, 2016
$656K grant received from NIH and NIDCR.
For institutional investors. Book with your work email.
Rheonix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rheonix's valuation, stock price, and market status.
Is Rheonix a public or private company?
Rheonix is a private company.
What is the current stock price of Rheonix?
Rheonix is a private company, so its shares have no public market price. Caplight tracks Rheonix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rheonix worth (valuation)?
Valuation information for Rheonix is not publicly available.
Can I buy Rheonix stock?
Rheonix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rheonix's last funding round?
Rheonix's most recent funding round was Debt on June 18, 2020.
Who are the main investors in Rheonix?
Key investors in Rheonix include Limestone Capital Advisors, Advantage Capital, Onondaga Venture Capital Fund, Cayuga Venture Fund, Rand Capital BDC.
Will Rheonix IPO soon?
No public IPO plans have been announced for Rheonix.
How can I track Rheonix secondary market activity?
Caplight tracks bids, offers, and trades in Rheonix's shares on secondary markets.